Nateglinide vs. Glipizide: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Nateglinide and Glipizide. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 89,355 people who take Nateglinide and Glipizide, and is updated regularly.
What is Nateglinide?
Nateglinide has active ingredients of nateglinide. It is often used in type 2 diabetes. eHealthMe is studying from 1,771 Nateglinide users. Check the latest studies of Nateglinide.
What is Glipizide?
Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
89,355 people who take Nateglinide and Glipizide are studied.
Drugs being compared in this study:
- Glipizide (glipizide)
- Nateglinide (nateglinide)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Nateglinide:
- not at all: 2.5 %
- somewhat: 7.5 %
- moderate: 45.0 %
- high: 45.0 %
- very high: 0 %
Glipizide:
- not at all: 2.71 %
- somewhat: 20.38 %
- moderate: 41.93 %
- high: 28.03 %
- very high: 6.95 %
Want to compare Nateglinide with Glipizide?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
- Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Nateglinide (1,756 reports)
- Glipizide (63,676 reports)
Browse all side effects of Nateglinide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Glipizide:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on nateglinide and glipizide (the active ingredients of Nateglinide and Glipizide, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Symbicort and Ipratropium Bromide drug interactions for women aged 50-59 - now
- Could Velcade cause Hyperpyrexia? - a second ago
- Drug interactions of Quetiapine Fumarate and Fenofibrate - 7 seconds ago
- Could Calcium Carbonate cause Dysstasia? - 10 seconds ago
- Could Valium cause Poisoning? - 17 seconds ago
- Could Alli cause Hypersensitivity? - 28 seconds ago
- Could Cabergoline cause Hepatic Pain? - 37 seconds ago
- Could Bumex cause Kidney Infection (Pyelonephritis)? - a minute ago
- Could Tylenol cause Resorption Bone Increased? - a minute ago
- Combivir and Thrombocytopenia for Men aged 50-59 - a minute ago